A carregar...

Recurrent SERPINB3 and SERPINB4 Mutations in Patients that Respond to Anti-CTLA4 Immunotherapy

Immune checkpoint blockade has shown significant promise as an anti-cancer treatment, yet the determinants of response are not completely understood. Here, we show that somatic mutations in SERPINB3 and SERPINB4 are associated with survival following anti-CTLA4 immunotherapy in two independent cohor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Genet
Main Authors: Riaz, Nadeem, Havel, Jonathan J., Kendall, Sviatoslav M., Makarov, Vladimir, Walsh, Logan A., Desrichard, Alexis, Weinhold, Nils, Chan, Timothy A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553281/
https://ncbi.nlm.nih.gov/pubmed/27668655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ng.3677
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!